Susquehanna International Group
TCRT icon

Susquehanna International Group’s Alaunos Therapeutics TCRT Stock Holding History

Susquehanna International Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-229
Closed -$2.4K – 13307
2023
Q4 		$2.4K Sell
229
-10
-4% -$120 ﹤0.01% 12167
2023
Q3 		$4.65K Sell
239
-23
-9% -$991 ﹤0.01% 11799
2023
Q2 		$20K Buy
262
+21
+9% +$1.7K ﹤0.01% 11635
2023
Q1 		$22.8K Sell
241
-92
-28% -$8.76K ﹤0.01% 12012
2022
Q4 		$32.4K Sell
333
-1,452
-81% -$210K ﹤0.01% 11598
2022
Q3 		$460K Buy
1,785
+1,330
+292% +$386K ﹤0.01% 8718
2022
Q2 		$85K Sell
455
-184
-29% -$17.6K ﹤0.01% 11622
2022
Q1 		$62K Sell
639
-874
-58% -$112K ﹤0.01% 12211
2021
Q4 		$247K Sell
1,513
-382
-20% -$83.9K ﹤0.01% 10973
2021
Q3 		$517K Sell
1,895
-158
-8% -$48.3K ﹤0.01% 9319
2021
Q2 		$813K Buy
2,053
+21
+1% +$9.8K ﹤0.01% 8321
2021
Q1 		$1.1M Buy
2,032
+694
+52% +$432K ﹤0.01% 7492
2020
Q4 		$506K Sell
1,338
-201
-13% -$79.9K ﹤0.01% 8266
2020
Q3 		$582K Sell
1,539
-2,190
-59% -$968K ﹤0.01% 7365
2020
Q2 		$1.83M Sell
3,729
-644
-15% -$287K ﹤0.01% 4658
2020
Q1 		$1.61M Buy
4,373
+3,860
+752% +$2M ﹤0.01% 4376
2019
Q4 		$363K Sell
513
-2,743
-84% -$1.89M ﹤0.01% 7624
2019
Q3 		$2.09M Sell
3,256
-1,883
-37% -$1.49M ﹤0.01% 4090
2019
Q2 		$4.49M Buy
5,139
+429
+9% +$295K ﹤0.01% 2862
2019
Q1 		$2.72M Buy
4,710
+2,645
+128% +$1.11M ﹤0.01% 3286
2018
Q4 		$579K Buy
2,065
+1,344
+186% +$531K ﹤0.01% 5744
2018
Q3 		$346K Sell
721
-70
-9% -$30K ﹤0.01% 7201
2018
Q2 		$358K Buy
791
+172
+28% +$109K ﹤0.01% 7491
2018
Q1 		$364K Sell
619
-530
-46% -$330K ﹤0.01% 7277
2017
Q4 		$713K Sell
1,149
-708
-38% -$509K ﹤0.01% 5912
2017
Q3 		$1.71M Sell
1,857
-427
-19% -$379K ﹤0.01% 4194
2017
Q2 		$2.13M Sell
2,284
-4,370
-66% -$4.28M ﹤0.01% 3801
2017
Q1 		$6.33M Sell
6,654
-1,594
-19% -$1.48M ﹤0.01% 2098
2016
Q4 		$6.62M Sell
8,248
-1,223
-13% -$1.1M ﹤0.01% 2020
2016
Q3 		$8M Buy
9,471
+3,016
+47% +$2.42M ﹤0.01% 1723
2016
Q2 		$5.32M Sell
6,455
-934
-13% -$1.02M ﹤0.01% 2118
2016
Q1 		$8.22M Sell
7,389
-196
-3% -$201K ﹤0.01% 1742
2015
Q4 		$9.46M Buy
7,585
+3,018
+66% +$4.99M ﹤0.01% 1809
2015
Q3 		$6.17M Sell
4,567
-554
-11% -$914K ﹤0.01% 2383
2015
Q2 		$9.22M Sell
5,121
-3,960
-44% -$6.15M ﹤0.01% 2101
2015
Q1 		$14.7M Buy
9,081
+3,759
+71% +$5.57M 0.01% 1509
2014
Q4 		$4.05M Buy
5,322
+1,146
+27% +$608K ﹤0.01% 3190
2014
Q3 		$1.65M Buy
4,176
+180
+5% +$86.8K ﹤0.01% 4964
2014
Q2 		$2.42M Buy
3,996
+383
+11% +$213K ﹤0.01% 4292
2014
Q1 		$2.48M Sell
3,613
-1,342
-27% -$899K ﹤0.01% 3963
2013
Q4 		$3.23M Buy
4,955
+3,419
+223% +$2.04M ﹤0.01% 3549
2013
Q3 		$910K Sell
1,536
-2,298
-60% -$1.04M ﹤0.01% 5442
2013
Q2 		$1.21M Buy
+3,834
New +$1.06M ﹤0.01% 4680

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Susquehanna International Group's TCRT Position: Q1 2024 in Review

Susquehanna International Group sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 931 shares — an estimated $9.87K sold.

Susquehanna International Group first reported a position in TCRT in Q2 2013 and held it in 43 quarters. The position peaked at $49.1M in Q2 2017. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Susquehanna International Group reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 931 Alaunos Therapeutics shares in Q1 2024, an estimated $9.87K.
  • Susquehanna International Group first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 43 quarters.
  • Susquehanna International Group's Alaunos Therapeutics position peaked at $49.1M in Q2 2017.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.